Publicacións en colaboración con investigadores/as de Centro Nacional de Epidemiología (73)

2024

  1. Assessment of exposure to secondhand tobacco smoke in Spain: A scoping review

    Tobacco Induced Diseases, Vol. 22, Núm. October

  2. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802

  3. Towards stronger tobacco control policies to curb the smoking epidemic in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1561-1569

2023

  1. Changes in smoking cessation in Spain, 1987-2020

    Medicina Clinica, Vol. 160, Núm. 6, pp. 237-244

  2. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  3. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  4. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  5. Estimations of smoking-attributable mortality in Spain at a regional level: comparison of two methods

    Annals of Epidemiology, Vol. 82, pp. 77-83.e3

  6. Light cigarette smoking and all-cause mortality in Spain. A national population-based cohort study

    Annals of Epidemiology, Vol. 78, pp. 9-12

  7. Small-area models to assess the geographical distribution of tobacco consumption by sex and age in Spain

    Tobacco Induced Diseases, Vol. 21, Núm. May

  8. The duration of intervals on the oral cancer care pathway and implications for survival: a systematic review and meta-analysis

    Frontiers in Public Health, Vol. 11

2022

  1. Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool

    Journal of Clinical Epidemiology, Vol. 147, pp. 101-110

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  3. Smoking-attributable mortality in the autonomous communities of Spain, 2017

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 150-158

  4. Trends in smoking-attributable mortality in Spain: 1990-2018

    European journal of public health, Vol. 32, Núm. 6, pp. 919-925

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

2020

  1. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study (Scientific Reports, (2018), 8, 1, (3036), 10.1038/s41598-018-20832-0)

    Scientific Reports

  2. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  3. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1